Vimta Labs Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vimta Labs Limited with three other miscellaneous service companies in Asia: Trans Genic Inc of Japan (2017 sales of 2.30 billion Japanese Yen [US$20.70 million] of which 50% was CRO Business), PhoenixBio Co Ltd of Japan (1.23 billion Japanese Yen [US$11.05 million] ), and Japan Tissue Engineering Company Limited which is also based in Japan (2.14 billion Japanese Yen [US$19.19 million] of which 96% was Regenerative Medicine Products Business).

Sales Analysis. During the year ended March of 2017, sales at Vimta Labs Limited were 1.53 billion Indian Rupees (US$23.82 million). This is an increase of 23.0% versus 2016, when the company's sales were 1.25 billion Indian Rupees.